Long-Lasting Weight Loss: Studies show that these medications support significant and long-lasting weight reduction when paired with a nutritious diet and consistent exercise
However, the right approach depends on each persons health history, current medications, nutritional needs, and individual circumstances
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 pounds (15 kilograms)
No aspiration needed: Aspiration (pulling back on plunger) is not necessary for subcutaneous injections, as there are no large blood vessels in subcutaneous tissue [11]
This article explores the science behind this innovative treatment, how it compares to older alternatives, and what you should consider when evaluating your options for managing your long term health
Are there other semaglutide options